It's been over 15 years since the publication of the Fourth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). The DSM-V is due to be published in May 2013, and for the first time, the American Psychiatric Association invited input from the wider medical community and the general public. Anyone could go to the website, view the draft criteria alongside DSM-IV criteria, as well as the rationale behind the proposed changes, and add their comments, through April 20, 2010. Dr. Darrel Regier, executive director of the American Psychiatric Institute for Research and Education and director, division of research, at the American Psychiatric Association, tells host Bruce Japsen about what's due to change in the Manual, and the ramifications for research, treatment, payment, and — ultimately — outcomes.
Rewriting the DSM
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
It's been over 15 years since the publication of the Fourth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). The DSM-V is due to be published in May 2013, and for the first time, the American Psychiatric Association invited input from the wider medical community and the general public. Anyone could go to the website, view the draft criteria alongside DSM-IV criteria, as well as the rationale behind the proposed changes, and add their comments, through April 20, 2010. Dr. Darrel Regier, executive director of the American Psychiatric Institute for Research and Education and director, division of research, at the American Psychiatric Association, tells host Bruce Japsen about what's due to change in the Manual, and the ramifications for research, treatment, payment, and — ultimately — outcomes.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
Love Story: Lipid Education for Women’s Heart Health
HF Management for Patients with Comorbid Conditions
Personalizing Care Within the RCC Treatment Paradigm
Navigating Myasthenia Gravis in Adolescents and Young Adults
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?